Early Stage Biotech CEO of Cytonics On Operating In A Recession, Osteoarthritis, and Career Ep.642

Random Musings From The Clinical Trials Guru - A podcast by Dan Sfera

Try Bookbeat 60! days for free, click here

Enjoy a whole world of audiobooks and e-books, everything from new releases to the classics

Sponsored

Categories:

Business

Dan interviews Joey Bose, CEO of Cytonics Corporation. Cytonics is a R&D company dedicated to discovering and developing therapeutics for musculoskeletal diseases based on the protease inhibitor Alpha-2-Macroglobulin (A2M).

Visit the podcast's native language site